The following biotech stocks featured on our site hit new highs yesterday.
* Last Closing Price refers to the stock's closing price on May 22, 2023.
Ticker
Published Date
Published Price
Maximum Price Since Publication
*Last Closing Price
Maximum Gain %
Akebia Therapeutics Inc. (AKBA)
Mar.22, 2023
$0.70
$1.63
$1.41
132%
VectivBio Holding AG (VECT)
May 4, 2023
$10.63
$16.45
$16.21
54%
Krystal Biotech, Inc. (KRYS)
Nov.9, 2022
$77.84
$120
$117.53
Immunovant Inc. (IMVT)
Oct.5, 2022
$7.84
$24.18
$23.75
208%
Alpine Immune Sciences Inc. (ALPN)
Mar.3, 2023
$7.97
$10.65
$10.51
33%
Voyager Therapeutics Inc. (VYGR)
Jan.11, 2023
$8.10
$14.34
$13.85
77%
RxSight Inc. (RXST)
Aug.10, 2022
$15.45
$26.77
$26.08
73%
10x Genomics Inc. (TXG)
Aug.9, 2022
$43.58
$58.30
$57.10
ACADIA Pharmaceuticals Inc. (ACAD)
Apr.18, 2023
$19.49
$24.85
$24.80
27%
Accuray Inc. (ARAY)
Feb.16, 2023
$3.14
$3.80
$3.78
21%
Exact Sciences Corp. (EXAS)
Nov.7, 2022
$37.80
$84.99
$83.61
124%
Delcath Systems Inc. (DCTH)
Mar.27, 2023
$5.75
$7.20
$7.05
25%
PTC Therapeutics Inc. (PTCT)
Dec.29, 2022
$36.01
$59.84
$59.10
66%
argenx SE (ARGX)
Dec.1, 2022
$404.85
$423.99
$419.70
4%
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.